ArticleMedical & biological engineering & computing2026
GAD-YOLO: a gastrointestinal abnormality detection YOLO model with multi-scale channel attention and residual fusion.
Article in Medical & biological engineering & computing, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Gastrointestinal endoscopy is indispensable for early detection and treatment of gastrointestinal diseases. However, the diagnostic precision and sensitivity of current computer-aided diagnosis systems remain limited, particularly for lesions with small size, low visibility, or poorly defined boundaries. In this paper, we propose a Gastrointestinal Abnormality Detection YOLO model (termed GAD-YOLO), which is built upon the YOLOv8s architecture and enhanced with multi-scale channel attention and residual fusion to improve the detection accuracy and robustness in gastrointestinal endoscopy. In the backbone, two improved modules, MSC2f and D4f, are integrated to strengthen cross-scale feature representation and hierarchical context fusion, enhancing the model’s capability in capturing multi-scale lesion features. In particular, the MSC2f module is designed to enhance the detection sensitivity for diminutive and flat lesions, which are frequently overlooked during routine gastrointestinal endoscopic examinations but are critical for early-stage disease identification. In the neck, a newly designed SEC2f module adaptively recalibrates channel responses after multi-scale feature fusion, thereby refining fused representations and reducing missed detections. The proposed model was trained and evaluated on the public Kvasir-Capsule dataset and compared with five YOLO variants, SSD, and Faster R-CNN. GAD-YOLO achieved a mean Average Precision (mAP) of 0.974, outperforming all baseline models by 1.4%–29.7%. These findings indicate that GAD-YOLO has the potential to support reliable identification of subtle and clinically relevant gastrointestinal lesions in complex endoscopic scenarios.
Indexed as
Identifiers
41831192What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.